Try our Advanced Search for more refined results

January 11, 2021

Pfizer Inc. et al v. Aurobindo Pharma Ltd. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 12, 2021

    Pfizer Sues Over Generic For Arthritis Drug Xeljanz

    Pharmaceutical giant Pfizer has asked a Delaware federal court to block generic-drug maker Aurobindo Pharma from moving ahead with plans to sell a generic version of arthritis drug Xeljanz that Pfizer says would infringe two patents it owns.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login